Women specificities in healthcare are gaining importance due to the higher socieconomical status in developed countries and insights from research highlighting sex and gender disparities in the development, prevention and treatment of diseases. As an example, cardiovascular disease remains the leading cause of death among women in the EU, yet it is still under-researched, frequently misdiagnosed, and often undertreated. Understanding women's health requires moving beyond a "one-size-fits-all" medical model to one that recognizes the profound impact of sex and gender on health outcomes and considers the differential needs in prevention and treatment. In parallel, there is a growing high-tech market delivering new healthcare products and services specifically designed for women, the so-called femtech sector, with innovations specifically designed for women’s wellness or care related to diagnostic devices, wearable sensors, etc. This panel will analyze this healthcare paradigm change and the related technological innovations as well as the integration of these aspects into routine clinical workflows by multidisciplinary experts including a cardiologist with expertise in digital health and AI, pharma and femtech companies.
- Representante de Abbvie –TBC.
- Representante de Qassay –TBC.
